[Inhibitory effects of macrolides on exaggerated production of vascular endothelial growth factor (VEGF) caused by co-stimulation by hypoxia and TNF-alpha].
Matsune
Akishi
A
Sun
Do
D
Obori
Junichiro
J
Ushikai
Masato
M
Kurono
Yuichi
Y
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D015687:Cell Hypoxia / Q000502:physiology*; D002478:Cells, Cultured; D017291:Clarithromycin / Q000494:pharmacology*; D003907:Dexamethasone / Q000494:pharmacology; D006801:Humans; D015575:Roxithromycin / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis*
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D014409:Tumor Necrosis Factor-alpha; D042461:Vascular Endothelial Growth Factor A; D015575:Roxithromycin; D003907:Dexamethasone; D017291:Clarithromycin